Bladder Cancer Market Information, by Types (Transitional Cell Carcinoma, Squamous Cell Carcinoma and Adenocarcinoma), by Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Radical Cystectomy and Others) by End Users (Hospital, Clinic, Cancer Care Centers and Others) - Forecast to 2022
Pune, India -- (SBWIRE) -- 07/19/2017 -- Market Summary:
The global bladder cancer market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. There has been a tremendous growth in the number of people getting diagnosed with bladder cancer. Men are seen to be more prone to bladder cancer than women. According to the National Institutes of Health, approximately 45,000 men and 17,000 women per year are diagnosed with the disease only in U.S. The exact reason causing bladder cancer is unknown.
However, there are few risk factors which can cause bladder cancer such as successive exposure to radiation, previous cancer treatments, excessive smoking, and chronic bladder infection among others. The most common treatment for the bladder cancer is chemotherapy.
Major Key Players
- AstraZeneca plc.,
- Bristol-Myers Squibb,
- Celgene Corporation,
- Eli Lilly and Co.,
- F. Hoffmann-La Roche,
- GlaxoSmithKline plc.,
- Novartis International AG,
- Pfizer Inc.,
- Sanofi S.A.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1899
- Bladder cancer treatment devices manufacturers & Suppliers
- Bladder cancer treatment drug manufacturers & Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Academic Institutes and Universities
Market Research Analysis:
In the coming years, the bladder cancer market will advance globally more than it has in the past several years. There is no specific age for the development of the bladder cancer. It can develop at any age; however the chances of getting bladder cancer get high as the person gets old. North America is the region leading the market of bladder cancer. However, the prevalence of bladder cancer is increasing rapidly in the Asia-Pacific region where India being the major country having huge number of patients diagnosed with the disease. With the development of modified therapies and combinational use of the therapies, bladder cancer treatment is going to be a major money spinner in the near future.
Test the market data and market information presented through more than 50 market data tables and figures spread over 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Bladder Cancer Market Research Report –Global Forecast to 2022."
Bladder cancer market has been segmented on the basis of types which comprises of transitional cell carcinoma, squamous cell carcinoma and adenocarcinoma. On the basis of treatments, market is segmented into chemotherapy, radiation therapy, immunotherapy, radical cystectomy and others. On the basis of end user, market is segmented into hospital, clinic, cancer care centers and others.
Regional Analysis of Bladder Cancer Market:
Globally North America is the largest market for bladder cancer. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for bladder cancer.
Access Report Details @ https://www.marketresearchfuture.com/reports/bladder-cancer-market
Table of Content
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
List of Tables
TABLE 1 GLOBAL BLADDER CANCER MARKET, BY TYPES, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL BLADDER CANCER MARKET, BY TREATMENT, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL BLADDER CANCER MARKET, BY END USER, 2013-2022 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL BLADDER CANCER MARKET, BY TYPES
FIGURE 4 GLOBAL BLADDER CANCER MARKET, BY TREATMENT
Browse Related Statistical report
North America Dental suture market is estimated to grow at CAGR of 5.4%. North America is the largest market for the dental suture and U.S contributes large market share of 79.9%. The U.S market is expected to reach $197.04 million by 2027 from $99.47 million in 2015.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312